These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

385 related items for PubMed ID: 15312984

  • 1. Sequential activation of soluble guanylate cyclase, protein kinase G and cGMP-degrading phosphodiesterase is necessary for proper induction of long-term potentiation in CA1 of hippocampus. Alterations in hyperammonemia.
    Monfort P, Muñoz MD, Kosenko E, Llansola M, Sánchez-Pérez A, Cauli O, Felipo V.
    Neurochem Int; 2004 Nov; 45(6):895-901. PubMed ID: 15312984
    [Abstract] [Full Text] [Related]

  • 2. Long-term potentiation in hippocampus involves sequential activation of soluble guanylate cyclase, cGMP-dependent protein kinase, and cGMP-degrading phosphodiesterase.
    Monfort P, Muñoz MD, Kosenko E, Felipo V.
    J Neurosci; 2002 Dec 01; 22(23):10116-22. PubMed ID: 12451112
    [Abstract] [Full Text] [Related]

  • 3. Hyperammonemia impairs long-term potentiation in hippocampus by altering the modulation of cGMP-degrading phosphodiesterase by protein kinase G.
    Monfort P, Muñoz MD, Felipo V.
    Neurobiol Dis; 2004 Feb 01; 15(1):1-10. PubMed ID: 14751765
    [Abstract] [Full Text] [Related]

  • 4. Molecular mechanisms of the alterations in NMDA receptor-dependent long-term potentiation in hyperammonemia.
    Monfort P, Muñoz MD, Felipo V.
    Metab Brain Dis; 2005 Dec 01; 20(4):265-74. PubMed ID: 16382337
    [Abstract] [Full Text] [Related]

  • 5. Chronic hyperammonemia in vivo impairs long-term potentiation in hippocampus by altering activation of cyclic GMP-dependent-protein kinase and of phosphodiesterase 5.
    Monfort P, Muñoz MD, Felipo V.
    J Neurochem; 2005 Aug 01; 94(4):934-42. PubMed ID: 16092938
    [Abstract] [Full Text] [Related]

  • 6. Long-term potentiation in hippocampus involves sequential activation of soluble guanylate cyclase, cGMP-dependent protein kinase and cGMP-degrading phosphodiesterase, alterations in hyperammonemia.
    Monfort P, Felipo V.
    BMC Pharmacol; 2005 Jun 16; 5 Suppl 1(Suppl 1):P66. PubMed ID: 15969770
    [No Abstract] [Full Text] [Related]

  • 7. On the role of nitric oxide in hippocampal long-term potentiation.
    Bon CL, Garthwaite J.
    J Neurosci; 2003 Mar 01; 23(5):1941-8. PubMed ID: 12629199
    [Abstract] [Full Text] [Related]

  • 8. Role of guanylyl cyclase and cGMP-dependent protein kinase in long-term potentiation.
    Zhuo M, Hu Y, Schultz C, Kandel ER, Hawkins RD.
    Nature; 1994 Apr 14; 368(6472):635-9. PubMed ID: 7908417
    [Abstract] [Full Text] [Related]

  • 9. Hyperammonemia impairs NMDA receptor-dependent long-term potentiation in the CA1 of rat hippocampus in vitro.
    Muñoz MD, Monfort P, Gaztelu JM, Felipo V.
    Neurochem Res; 2000 Apr 14; 25(4):437-41. PubMed ID: 10823575
    [Abstract] [Full Text] [Related]

  • 10. Alterations in soluble guanylate cyclase content and modulation by nitric oxide in liver disease.
    Rodrigo R, Montoliu C, Chatauret N, Butterworth R, Behrends S, Del Olmo JA, Serra MA, Rodrigo JM, Erceg S, Felipo V.
    Neurochem Int; 2004 Nov 14; 45(6):947-53. PubMed ID: 15312989
    [Abstract] [Full Text] [Related]

  • 11. Amyloid-β impairs, and ibuprofen restores, the cGMP pathway, synaptic expression of AMPA receptors and long-term potentiation in the hippocampus.
    Monfort P, Felipo V.
    J Alzheimers Dis; 2010 Nov 14; 22(3):795-809. PubMed ID: 20858955
    [Abstract] [Full Text] [Related]

  • 12. Feedback control through cGMP-dependent protein kinase contributes to differential regulation and compartmentation of cGMP in rat cardiac myocytes.
    Castro LR, Schittl J, Fischmeister R.
    Circ Res; 2010 Nov 12; 107(10):1232-40. PubMed ID: 20847310
    [Abstract] [Full Text] [Related]

  • 13. Evidence for involvement of the cGMP-protein kinase G signaling system in the induction of long-term depression, but not long-term potentiation, in the dentate gyrus in vitro.
    Wu J, Wang Y, Rowan MJ, Anwyl R.
    J Neurosci; 1998 May 15; 18(10):3589-96. PubMed ID: 9570790
    [Abstract] [Full Text] [Related]

  • 14. Brain regional alterations in the modulation of the glutamate-nitric oxide-cGMP pathway in liver cirrhosis. Role of hyperammonemia and cell types involved.
    Rodrigo R, Felipo V.
    Neurochem Int; 2006 May 15; 48(6-7):472-7. PubMed ID: 16517021
    [Abstract] [Full Text] [Related]

  • 15. Exogenous nitric oxide causes potentiation of hippocampal synaptic transmission during low-frequency stimulation via the endogenous nitric oxide-cGMP pathway.
    Bon CL, Garthwaite J.
    Eur J Neurosci; 2001 Aug 15; 14(4):585-94. PubMed ID: 11556884
    [Abstract] [Full Text] [Related]

  • 16. A critical role of NO/cGMP/PKG dependent pathway in hippocampal post-ischemic LTP: modulation by zonisamide.
    Costa C, Tozzi A, Siliquini S, Galletti F, Cardaioli G, Tantucci M, Pisani F, Calabresi P.
    Neurobiol Dis; 2011 Nov 15; 44(2):185-91. PubMed ID: 21749921
    [Abstract] [Full Text] [Related]

  • 17. cGMP catabolism by phosphodiesterase 5A regulates cardiac adrenergic stimulation by NOS3-dependent mechanism.
    Takimoto E, Champion HC, Belardi D, Moslehi J, Mongillo M, Mergia E, Montrose DC, Isoda T, Aufiero K, Zaccolo M, Dostmann WR, Smith CJ, Kass DA.
    Circ Res; 2005 Jan 07; 96(1):100-9. PubMed ID: 15576651
    [Abstract] [Full Text] [Related]

  • 18. Gender differences in spatial learning, synaptic activity, and long-term potentiation in the hippocampus in rats: molecular mechanisms.
    Monfort P, Gomez-Gimenez B, Llansola M, Felipo V.
    ACS Chem Neurosci; 2015 Aug 19; 6(8):1420-7. PubMed ID: 26098845
    [Abstract] [Full Text] [Related]

  • 19. HIV-1 coat protein gp120 decreases NO-dependent cyclic GMP accumulation in rat brain astroglia by increasing cyclic GMP phosphodiesterase activity.
    Navarra M, Baltrons MA, Sardón T, Pedraza CE, García A.
    Neurochem Int; 2004 Nov 19; 45(6):937-46. PubMed ID: 15312988
    [Abstract] [Full Text] [Related]

  • 20. Nitric oxide and carbon monoxide as possible retrograde messengers in hippocampal long-term potentiation.
    Hawkins RD, Zhuo M, Arancio O.
    J Neurobiol; 1994 Jun 19; 25(6):652-65. PubMed ID: 8071665
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.